1. MicroRNA-199a-5p attenuates blood-brain barrier disruption following ischemic stroke by regulating PI3K/Akt signaling pathway.
- Author
-
Ni G, Kou L, Duan C, Meng R, and Wang P
- Subjects
- Animals, Male, Rats, Infarction, Middle Cerebral Artery metabolism, Infarction, Middle Cerebral Artery genetics, Infarction, Middle Cerebral Artery pathology, Apoptosis, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor A genetics, Brain Ischemia metabolism, Brain Ischemia genetics, Brain Ischemia pathology, MicroRNAs genetics, MicroRNAs metabolism, Blood-Brain Barrier metabolism, Proto-Oncogene Proteins c-akt metabolism, Signal Transduction, Rats, Sprague-Dawley, Ischemic Stroke metabolism, Ischemic Stroke genetics, Ischemic Stroke pathology, Phosphatidylinositol 3-Kinases metabolism
- Abstract
Objective: To explore whether miR-199a-5p regulated BBB integrity through PI3K/Akt pathway after ischemia stroke., Methods: Adult male Sprague-Dawley rats with permanent middle cerebral artery occlusion(MCAO) were used in experiment. The Ludmila Belayev 12-point scoring was used to measure the neurological function of MCAO rats. The Evans Blue Stain, immunofluorescence staining, western-blotting and RT-PCR were performed to evaluate the effects of miR-199a-5p mimic on BBB integrity in rats following MCAO., Results: The result suggested that miR-199a-5p mimic treatment possessed the potential to boost proprioception and motor activity of MCAO rats. MiR-199a-5p decreased the expression of PIK3R2 after MCAO, activated Akt signaling pathway, and increased the expression of Claudin-5 and VEGF in the ischemic penumbra. Furthermore, miR-199a-5p alleviated inflammation after cerebral ischemia. BBB leakage and neurocyte apoptosis were cut down in MCAO rats treated with miR-199a-5p mimic., Conclusions: MiR-199a-5p mimic decreased the expression of PIK3R2 and activated Akt signaling pathway after ischemia stroke, reduced the expression of inflammatory cytokines, and attenuated BBB disruption after ischemic stroke., Competing Interests: All authors declare that they have no conflicts of interest to report., (Copyright: © 2024 Ni et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF